Latest Breaking News On - Urogen pharma company profile - Page 1 : comparemela.com

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Urogen pharmaMark schoenbergChina universal asset management coSecurities exchange commissionAllspring global investments holdingsSierra summit advisorsSg americas securitiesUrogen pharma company profileHermes incUrogen pharma ltdFree reportGen pharma stock downGen pharmaGet free reportExchange commissionGlobal investments holdings

UroGen Pharma s (URGN) Buy Rating Reiterated at HC Wainwright

UroGen Pharma s (URGN) Buy Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Urogen pharmaMark schoenbergUrogen pharma company profileHermes incAllspring global investments holdingsSg americas securitiesSierra summit advisorsChina universal asset management coUrogen pharma ltdFree reportGen pharma trading downGen pharmaGet free reportUniversal asset managementGlobal investments holdingsGen pharma ltd

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Urogen pharmaMark schoenbergAllspring global investments holdingsUrogen pharma company profileGroup plcLazard asset managementAcadian asset managementUrogen pharma ltdFree reportGen pharma stock downGen pharmaGet free reportGeneral counsel jason drew smithAsset managementGeneral group plcGlobal investments holdings

UroGen Pharma (URGN) Scheduled to Post Quarterly Earnings on Thursday

UroGen Pharma (NASDAQ:URGN – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, March 14th. Analysts expect the company to announce earnings of ($0.67) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link. UroGen Pharma Trading Down […]

Urogen pharmaMark schoenbergGroup plcUrogen pharma ltdUrogen pharma company profileAcadian asset managementLazard asset managementGet free reportGen pharma trading downGen pharmaGeneral counsel jason drew smithGeneral group plcAsset managementGen pharma ltdUrogen pharma daily

Insider Selling: UroGen Pharma Ltd (NASDAQ:URGN) Insider Sells 3,789 Shares of Stock

UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) insider Mark Schoenberg sold 3,789 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $15.74, for a total transaction of $59,638.86. Following the sale, the insider now directly owns 149,423 shares of the […]

United statesUrogen pharmaMark schoenbergSecurities exchange commissionUrogen pharma ltdUrogen pharma company profileAlphacentric advisorsAmerican international group incAcadian asset managementGet free reportExchange commissionGen pharmaInternational groupAsset managementBridge advisorsCapital management